Acquired Organization:
- Raven Biotechnologies
Raven biotechnologies is focused on the development of monoclonal antibody therapeutics for the treatment of cancer.
Acquiring Organization:
- MacroGenics
MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.
Announced Date Jul 17, 2008